ThermalTherapeutic Systems, Inc. (TTS), maker of portable hyperthermic perfusion devices, today announced the appointment of Gardiner F.H. Smith as President and Chief Executive Officer. Mr. Smith joins TTS with 20 years’ experience as an operational executive in the high-tech sector, focused on biotech, medical devices and pharmaceuticals. Co-founder and previous CEO Raymond F. Vennare will transition to the role of Executive Vice President, Strategic Planning.

“Thermal Therapeutic Systems is positioned to provide medical professionals with the most advanced technology in the field of hyperthermic perfusion,” said Mr. Smith. “We have an FDA-cleared device that is being used by leading physicians in the treatment of critically ill cancer patients. Our product, VERATHERM^TM, fills an unmet medical need in North America, Europe and Asia. We continue to invest in providing our customers the tools and service support they need which enable them to treat patients with the best available therapeutic regimen on a cost efficient basis.”

Peter M. DeComo, Chairman of the Board said, “Thermal Therapeutic Systems is a growth stage company launching a ‘disruptive’ new product into the marketplace. Gardiner’s impressive track record of building successful companies and guiding them through growth and product launch makes him a tremendous addition to the TTS team at a critical time in our development. I am confident Thermal Therapeutic Systems is poised for continued growth to become the market leader.”

Mike Gausling, Managing Partner of Originate Ventures said, “We are grateful to Raymond for his strong leadership to guide us from inception through the FDA clearance for VERATHERM^TM.  As we shift our focus to being a commercial enterprise, we are delighted that Gardiner Smith has agreed to join the company to lead our sales and marketing efforts to establish VERATHERM^TM as the new standard of care in the field of hyperthermic perfusion.”